JUBLPHARMA.NS

Jubilant Pharmova Limited JUBLPHARMA.NS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode JUBLPHARMA.NS APLLTD.BO APLLTD.NS CAPLIPOINT.NS NATCOPHARM.NS NATCOPHARM.BO GRANULES.BO GRANULES.NS CONCORDBIO.BO CONCORDBIO.NS
6M 17.89 % 10.26 % 10.47 % 4.24 % -0.43 % -0.34 % 18.25 % 18.61 % -10.42 % -10.59 %
YTD -0.01 % -10.57 % -10.52 % -20.89 % -40.87 % -40.93 % -4.97 % -4.66 % -28.66 % -28.75 %
1Y -8.76 % -17.84 % -17.72 % 4.73 % -39.84 % -39.73 % -3.92 % -3.60 % -21.93 % -21.70 %
3Y 236.70 % 69.42 % 69.81 % 172.26 % 40.43 % 40.13 % 60.04 % 59.94 % 62.79 % 62.38 %
5Y 53.95 % -3.94 % -3.50 % 268.89 % -9.92 % -10.32 % 45.14 % 45.40 % 62.79 % 62.38 %
10Y 177.30 % 30.58 % 30.52 % 643.86 % 58.68 % 59.13 % 267.14 % 269.00 % 62.79 % 62.38 %
From the beginning 1 945.46 % 1 942.48 % 1 958.33 % 5 451.96 % 4 541.57 % 29 407.14 % 18 527.87 % 5 365.93 % 62.79 % 62.38 %

Dividend

Jubilant Pharmova Limited

Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited

Caplin Point Laboratories Limited

NATCO Pharma Limited

NATCO Pharma Limited

Granules India Limited

Granules India Limited

Concord Biotech Limited

Concord Biotech Limited